Clinical trial
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
NCT01797562 is registered in ClinicalTrials.gov with Allerderm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
- Lead sponsor
- Allerderm
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 10, 2012
- Completion date
- September 8, 2015
- Enrollment
- 116 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
allergic contact dermatitis